FSD PHARMA INC-CLASS B (HUGE) Stock Price, Quote, News and Overview
NASDAQ:HUGE - Nasdaq - CA35954B4047 - Common Stock - Currency: USD
HUGE Quote, Performance and Key Statistics
0.0899
-0.01 (-10.1%)
The current stock price of HUGE is 0.0899 USD. In the past month the price decreased by -40.82%. In the past year, price decreased by -93.22%.
HUGE Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 67.49 | 832.86B | ||
| JNJ | JOHNSON & JOHNSON | 16.28 | 391.53B | ||
| NVO | NOVO-NORDISK A/S-SPONS ADR | 27.56 | 391.52B | ||
| AZN | ASTRAZENECA PLC-SPONS ADR | 20.55 | 230.09B | ||
| MRK | MERCK & CO. INC. | 11.65 | 225.19B | ||
| NVS | NOVARTIS AG-SPONSORED ADR | 13.79 | 216.21B | ||
| PFE | PFIZER INC | 8.48 | 149.50B | ||
| SNY | SANOFI-ADR | 13.59 | 136.30B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 48.97 | 113.22B | ||
| GSK | GSK PLC-SPON ADR | 7.8 | 74.68B | ||
| ZTS | ZOETIS INC | 27.11 | 72.41B | ||
| TAK | TAKEDA PHARMACEUTIC-SP ADR | 31.97 | 44.59B |
Related stock screener links
About HUGE
Company Profile
FSD Pharma, Inc. is a biotechnology pharmaceutical research and development company, which focuses on the cultivation, process, and sale of medical cannabis. The company is headquartered in Toronto, Ontario. The company went IPO on 2018-05-29. The firm operates through two segments: Biotechnology and Strategic Investments. Its Biotechnology segment is focused on furthering the research and development of the Company’s two primary drug candidates consisting of Lucid-MS and Lucid-PSYCH, as well as the development of UNBUZZD. The Company’s Strategic Investments segment is focused on generating returns and cashflow through the issuance of loans secured by residential or commercial real estate property. Lucid-PSYCH is a molecular compound identified for the potential treatment of mental health disorders. Lucid-MS is a molecular compound identified for the potential treatment of neurodegenerative disorders. UNBUZZD is a proprietary formulation of natural ingredients, vitamins, and minerals to help with liver and brain function for the purposes of potentially quickly relieving from the effects of alcohol consumption, such as inebriation, and restoring normal lifestyle.
Company Info
FSD PHARMA INC-CLASS B
55 University Ave. , Suite 1003
TORONTO ONTARIO M5X 1A4 CA
CEO: Raza Bokhari
Employees: 10
Company Website: https://www.fsdpharma.com/
Phone: 14168548884
FSD PHARMA INC-CLASS B / HUGE FAQ
What is the stock price of FSD PHARMA INC-CLASS B today?
The current stock price of HUGE is 0.0899 USD. The price decreased by -10.1% in the last trading session.
What is the ticker symbol for FSD PHARMA INC-CLASS B stock?
The exchange symbol of FSD PHARMA INC-CLASS B is HUGE and it is listed on the Nasdaq exchange.
On which exchange is HUGE stock listed?
HUGE stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for FSD PHARMA INC-CLASS B stock?
7 analysts have analysed HUGE and the average price target is 7.83 USD. This implies a price increase of 8606.04% is expected in the next year compared to the current price of 0.0899. Check the FSD PHARMA INC-CLASS B stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is FSD PHARMA INC-CLASS B worth?
FSD PHARMA INC-CLASS B (HUGE) has a market capitalization of 3.64M USD. This makes HUGE a Nano Cap stock.
How many employees does FSD PHARMA INC-CLASS B have?
FSD PHARMA INC-CLASS B (HUGE) currently has 10 employees.
What are the support and resistance levels for FSD PHARMA INC-CLASS B (HUGE) stock?
FSD PHARMA INC-CLASS B (HUGE) has a resistance level at 0.1. Check the full technical report for a detailed analysis of HUGE support and resistance levels.
Should I buy FSD PHARMA INC-CLASS B (HUGE) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of HUGE, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of HUGE, evaluating the profitability, health, valuation and growth aspects
- FSD PHARMA INC-CLASS B (HUGE) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- FSD PHARMA INC-CLASS B (HUGE) Sales and EPS estimates to see what analysts future expectations are.
- FSD PHARMA INC-CLASS B (HUGE) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- FSD PHARMA INC-CLASS B (HUGE) Insider and Institutional Ownership to learn about the owners and their transactions.
- FSD PHARMA INC-CLASS B (HUGE) Stock Chart to make your own analysis
- FSD PHARMA INC-CLASS B (HUGE) Latest news and press-releases to stay up to date.
Does FSD PHARMA INC-CLASS B (HUGE) stock pay dividends?
HUGE does not pay a dividend.
When does FSD PHARMA INC-CLASS B (HUGE) report earnings?
FSD PHARMA INC-CLASS B (HUGE) will report earnings on 2024-11-12, before the market open.
HUGE Technical Analysis
HUGE Financial Highlights
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | N/A | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
HUGE Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 83% to HUGE. The Buy consensus is the average rating of analysts ratings from 7 analysts.